LBA41A double-blind, placebo-controlled, randomized, phase...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

LBA41A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma

Ledermann, J., Sehouli, J., Zurawski, B., Raspagliesi, F., De Giorgi, U., Banerjee, S., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R.L., Mihutiu, S., Markowska, J., Cebotaru, C., Herrae
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.035
Date:
September, 2017
File:
PDF, 66 KB
english, 2017
Conversion to is in progress
Conversion to is failed